← Leaderboards
Leslee J Shaw
Icahn School Of Medicine At Mount Sinai
$10,115,669
Attributed
$12,723,719
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2009–24$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,723,719 · 4
By mechanism
U01$6,488,634 · 1
R01$5,216,100 · 1
RC1$995,992 · 1
R13$22,993 · 1
Top collaborators
- Jagat Narula4 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Eva Velthorst$1,337,197
- Abraham Reichenberg$11,905,270
- Ivanka Markovic$641,021
- Rosamond Rhodes$2,689,208
- Melissa Pittel Wasserstein$13,874,586
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacReportingCoronaryCoronary ArteryEventPhysiciansLinkCoronary ArteriosclerosisMedicalAnatomyBaseData CollectionDiagnosticImageEnrollmentMyocardial InfarctionAngiographyHospitalizationCaringPharmaceutical PreparationsFollow-UpEffectivenessCost EffectivenessNuclear
Grant awards (15)
Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) accelerates atherosclerotic plaque progression$602,559
R01 · FY2024 · HL · contact PI
Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) accelerates atherosclerotic plaque progression$1,486,653
R01 · FY2023 · HL · contact PI
Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) alters atherosclerotic plaque progression$1,620,596
R01 · FY2021 · HL · contact PI
Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) accelerates atherosclerotic plaque progression$1,506,292
R01 · FY2021 · HL · contact PI
THE ISCHEMIA TRIAL - IICC$595,852
U01 · FY2018 · HL · contact PI
The ISCHEMIA Trial - IICC$96,782
U01 · FY2018 · HL · contact PI
The ISCHEMIA Trial - IICC$755,991
U01 · FY2017 · HL · contact PI
The ISCHEMIA Trial - IICC$1,018,577
U01 · FY2016 · HL · contact PI
The ISCHEMIA Trial - IICC$992,682
U01 · FY2015 · HL · contact PI
The ISCHEMIA Trial - IICC$1,061,285
U01 · FY2014 · HL · contact PI
The ISCHEMIA Trial - IICC$1,843,185
U01 · FY2012 · HL · contact PI
Radiation exposure during imaging and shared decision making$22,993
R13 · FY2012 · HL · contact PI
The ISCHEMIA Trial - IICC$124,280
U01 · FY2011 · HL · contact PI
Economic Consequences of Advanced Testing for Subclinical Cardiovascular Disease$497,966
RC1 · FY2010 · HL · contact PI
Economic Consequences of Advanced Testing for Subclinical Cardiovascular Disease$498,026
RC1 · FY2009 · HL · contact PI